Literature DB >> 1167471

Primary carcinoma of the gallbladder.

A T Prakash, L K Sharma, P N Pandit.   

Abstract

The clinical and pathological features of 100 consecutive cases of primary carcinoma of the gallbladder, treated by a single surgical unit, are described. Females out numbered males by 2 to 1. The maximum incidence was seen in the fifth decade. Pain and the presence of a mass were the two most common clinical features. Gallstones coexisted in 45 per cent of cases. Ancillary investigations were of little value in preoperative diagnosis. At laparotomy biopsy alone was possible in a large number of cases owing to the advanced disease process. Two patients were alive 5 years after surgery. Prophylactic cholecystectomy for all diseased gallbladders, whether symptomatic or not, is advocated.

Entities:  

Mesh:

Year:  1975        PMID: 1167471     DOI: 10.1002/bjs.1800620109

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Comparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience.

Authors:  Seong Yeon Cho; Sang-Jae Park; Seong Hoon Kim; Sung-Sik Han; Young-Kyu Kim; Kwang-Woong Lee
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 2.  Surgical progress 1975.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

3.  NATURAL HISTORY OF CARCINOMA OF THE GALLBLADDER AND ITS INFLUENCES ON MANAGEMENT.

Authors:  S K Kochar; P Subhas
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Carcinoma of the gall bladder presenting as a retrograde intussusception of the duodenum.

Authors:  N S Williams; B A Shorey
Journal:  Postgrad Med J       Date:  1978-05       Impact factor: 2.401

Review 5.  What should I do about my patient's gall stones?

Authors:  A R Dennison; D Azoulay; N Oakley; H Baer; J A Paraskevopoulos; G J Maddern
Journal:  Postgrad Med J       Date:  1995-12       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.